These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31803992)

  • 1. When is the optimal time to discontinue clopidogrel before in-hospital coronary bypass surgery? A closer look at the current literature.
    Mokhtar AT; Baghaffar A; Jackson SD; Horne D
    J Card Surg; 2020 Feb; 35(2):413-421. PubMed ID: 31803992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting.
    Holm M; Biancari F; Khodabandeh S; Gherli R; Airaksinen J; Mariscalco G; Gatti G; Reichart D; Onorati F; De Feo M; Santarpino G; Rubino AS; Maselli D; Santini F; Nicolini F; Zanobini M; Kinnunen EM; Ruggieri VG; Perrotti A; Rosato S; Dalén M
    Ann Thorac Surg; 2019 Jun; 107(6):1690-1698. PubMed ID: 30898561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
    Nakashima CAK; Dallan LAO; Lisboa LAF; Jatene FB; Hajjar LA; Soeiro AM; Furtado RHM; Dalçoquio TF; Baracioli LM; Lima FG; Giraldez RRCV; Silva BA; Costa MSS; Strunz CMC; Dallan LRP; Barbosa CJDG; Britto FAB; Farkouh ME; Gurbel PA; Nicolau JC
    J Am Coll Cardiol; 2021 Mar; 77(10):1277-1286. PubMed ID: 33706868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precatheterization Use of P2Y
    Badri M; Abdelbaky A; Li S; Chiswell K; Wang TY
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.
    Hansson EC; Jidéus L; Åberg B; Bjursten H; Dreifaldt M; Holmgren A; Ivert T; Nozohoor S; Barbu M; Svedjeholm R; Jeppsson A
    Eur Heart J; 2016 Jan; 37(2):189-97. PubMed ID: 26330426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
    Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S
    J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis.
    Cao C; Indraratna P; Ang SC; Manganas C; Park J; Bannon PG; Yan TD
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3092-8. PubMed ID: 24954178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.
    Reed GW; Kumar A; Guo J; Aranki S; Shekar P; Agnihotri A; Maree AO; McLean DS; Rosenfield K; Cannon CP
    Clin Cardiol; 2015 Feb; 38(2):92-8. PubMed ID: 25655085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
    Firstenberg MS; Dyke CM; Angiolillo DJ; Ramaiahm C; Price M; Brtko M; Welsby I; Chandna H; Holmes DR; Voeltz M; Tummala P; Hutyra M; Manoukian SV; Prats J; Todd M; Liu T; Chronos N; Dietrich M; Montalescot G; Cannon LA; Topo EJ
    Heart Surg Forum; 2013 Apr; 16(2):E60-9. PubMed ID: 23625478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y
    Guo CG; Chen L; Chan EW; Cheung KS; Isshiki T; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Jan; 49(1):7-19. PubMed ID: 30506985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Ticagrelor administration leads to a higher risk of bleeding during and after coronary bypass surgery in a case-matched analysis.
    Schaefer A; Sill B; Schoenebeck J; Schneeberger Y; Kubik M; Reichenspurner H; Gulbins H
    Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):136-40. PubMed ID: 26519259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention.
    Piqueras-Flores J; Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Abellán-Huerta J; Lozano-Ruiz Poveda F
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):56-59. PubMed ID: 30383607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prasugrel increases the need for platelet transfusions and surgical reexploration rates compared with clopidogrel in coronary artery bypass surgery.
    Drews S; Bolliger D; Kaiser C; Grapow M; Reuthebuch O; Eckstein F; Matt P
    Thorac Cardiovasc Surg; 2015 Feb; 63(1):28-35. PubMed ID: 24838516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
    Mahla E; Suarez TA; Bliden KP; Rehak P; Metzler H; Sequeira AJ; Cho P; Sell J; Fan J; Antonino MJ; Tantry US; Gurbel PA
    Circ Cardiovasc Interv; 2012 Apr; 5(2):261-9. PubMed ID: 22396581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis.
    Vuilliomenet T; Gebhard C; Bizzozero C; Glauser S; Blum S; Buser A; Bolliger D; Grapow MTR; Siegemund M
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):665-673. PubMed ID: 30535154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
    Mahla E; Tantry US; Prüller F; Gurbel PA
    Circulation; 2018 Nov; 138(19):2145-2159. PubMed ID: 30474416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
    Zanchin T; Temperli F; Karagiannis A; Zanchin C; Räsänen M; Koskinas KC; Stortecky S; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Billinger M; Heg D; Pilgrim T; Valgimigli M; Windecker S; Räber L
    Circ Cardiovasc Interv; 2018 May; 11(5):e006132. PubMed ID: 29748219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.